Marizyme Inc Sustainability Reports

Marizyme, Inc. operates as a life science and biomedical technology company focused on developing and commercializing medical devices, therapies, and diagnostics. Its core pipelines include platforms like DuraGraft for vascular graft protection and preservation.

Sector: Manufacturing

Country: United States

Exchange: OTC Markets

FIGI: BBG001T34YG3

No reports are currently available in our catalogue.